The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Valuation Is Forecasted For The Microbiome Sequencing Service Market By 2030 Starting From Its 2026 Size?
The microbiome sequencing service market size has experienced considerable growth over recent years. It is forecast to rise from $2.43 billion in 2025 to $2.84 billion in 2026, at a compound annual growth rate (CAGR) of 17.1%. The expansion observed in prior periods stems from the proliferation of microbiome research initiatives, an uptick in academic research funding, mounting interest in gut and skin microbiota studies, the widespread availability of next-generation sequencing platforms, and enhanced collaboration between academia and industry.
The market for microbiome sequencing services anticipates substantial expansion over the coming years. Projections indicate it will reach $5.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.8%. This expansion during the projection period stems from several factors: the growing clinical uptake of diagnostics based on microbiomes, escalating investments into microbiome therapeutics, the broadening scope of personalized nutrition research, the increasing application of AI-powered microbial analysis, and a heightened need for extensive population-level microbiome investigations. Key trends anticipated for this forecast timeframe encompass a surging need for high-throughput microbiome sequencing offerings, an expanding reliance on shotgun and amplicon sequencing techniques, the increasing incorporation of sophisticated bioinformatics pipelines, the broadening of clinical microbiome research applications, and a reinforced emphasis on profiling microbial functions.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28270&type=smp
What Primary Drivers Are Shaping The Development Of The Microbiome Sequencing Service Market?
The increasing occurrence of gut-related illnesses is projected to fuel the expansion of the microbiome sequencing service market in the future. These illnesses are medical conditions impacting the gastrointestinal (GI) tract, encompassing the stomach, intestines, and related organs like the liver, pancreas, and gallbladder. The surge in gut-related diseases stems from shifts in lifestyle and dietary practices, such as consuming excessive processed foods and insufficient fiber, which disturbs the equilibrium of gut microbiota. The microbiome sequencing service aids in managing gut-related diseases by providing comprehensive understanding of gut microbial makeup, making it suitable for identifying and overseeing gastrointestinal ailments. This service facilitates precise interventions by pinpointing microbial imbalances, enhancing tailored treatments, and improving overall gut health management. As an illustration, in June 2025, the UK Health Security Agency reported a 27.0% rise in laboratory reports for Campylobacter, from 96.1 to 122.0 per 100,000 population, between 2022 and 2024. Consequently, the growing prevalence of gut-related diseases is boosting the growth of the microbiome sequencing service market.
Which Segment Categories Define The Microbiome Sequencing Service Market?
The microbiome sequencing service market covered in this report is segmented –
1) By Service: Sample Preparation, Sequencing And Library Preparation, Data Analysis
2) By Technology: Sequencing By Litigation (SBL), Sequencing By Synthesis (SBS), Short Gun Sequencing, Targeted Gene Sequencing, RNA Sequencing, Other Technologies
3) By Application: Autoimmune Disorder, Cancer, Gastrointestinal Disorders, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Other End-Users
Subsegments:
1) By Sample Preparation: Deoxyribonucleic Acid (DNA) Extraction, Ribonucleic Acid (RNA) Extraction, Protein Extraction, Cell Lysis, Library Construction
2) By Sequencing And Library Preparation: Whole Genome Sequencing, Metagenomic Sequencing, Amplicon Sequencing, Shotgun Sequencing, Targeted Sequencing
3) By Data Analysis: Taxonomic Profiling, Functional Profiling, Comparative Analysis, Statistical Analysis, Pathway Analysis
Which Upcoming Trends Are Expected To Influence The Microbiome Sequencing Service Market?
Major companies operating within the microbiome sequencing service market are concentrating on developing advanced solutions, such as automated metagenomics sequencing tools, to enhance efficiency, accuracy, and scalability in microbiome research and analysis. An automated metagenomics sequencing solution is a comprehensive system designed to enable the sequencing and analysis of microbial communities with minimal manual intervention, thereby ensuring high accuracy, reproducibility, and scalable throughput. For instance, in July 2024, MGI Tech Co. Ltd., a China-based biotechnology company, unveiled its Human Microbiome Metagenomics Sequencing Package. This product provides a fully integrated workflow, incorporating automated sample pretreatment, nucleic acid extraction, library preparation, sequencing, and data analysis to support high-throughput and cost-efficient microbiome research. Its validated performance on a large number of human stool samples guarantees reproducibility and accuracy, thereby establishing a new standard for large-scale human microbiome studies.
Who Are The Top Companies Competing In The Microbiome Sequencing Service Market?
Major companies operating in the microbiome sequencing service market are Eurofins Scientific LLC, Illumina Inc., Charles River Laboratories, QIAGEN N.V., Mérieux NutriSciences Corporation, OraSure Technologies Inc., Zifo RnD Solutions, Novogene Co. Ltd., Oxford Nanopore Technologies Plc, Macrogen Inc., Zymo Research Corporation, CD Genomics, Molzym GmbH & Co. KG (Gradian Diagnostics), Baseclear BV, Psomagen Inc., Mapmygenome, Rancho Biosciences LLC, Boster Biological Technology Ltd., Clinical Microbiomics, Microba Life Sciences Limited
Read the full microbiome sequencing service market report here:
https://www.thebusinessresearchcompany.com/report/microbiome-sequencing-service-global-market-report
How Does The Microbiome Sequencing Service Market Perform Across Major Global Regions?
North America was the largest region in the microbiome sequencing service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microbiome sequencing service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Microbiome Sequencing Service Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28270&type=smp
Browse Through More Reports Similar to the Global Microbiome Sequencing Service Market 2026, By The Business Research Company
Supply Chain Security Global Market Report
https://www.thebusinessresearchcompany.com/report/supply-chain-security-global-market-report
Revenue Based Financing Global Market Report
https://www.thebusinessresearchcompany.com/report/revenue-based-financing-global-market-report
Healthcare Supply Chain Management Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model